15-32029282-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000636603.1(CHRNA7):​c.-131-1616T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.728 in 152,226 control chromosomes in the GnomAD database, including 41,887 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.73 ( 41887 hom., cov: 33)

Consequence

CHRNA7
ENST00000636603.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.935

Publications

10 publications found
Variant links:
Genes affected
CHRNA7 (HGNC:1960): (cholinergic receptor nicotinic alpha 7 subunit) The nicotinic acetylcholine receptors (nAChRs) are members of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. The nAChRs are thought to be hetero-pentamers composed of homologous subunits. The proposed structure for each subunit is a conserved N-terminal extracellular domain followed by three conserved transmembrane domains, a variable cytoplasmic loop, a fourth conserved transmembrane domain, and a short C-terminal extracellular region. The protein encoded by this gene forms a homo-oligomeric channel, displays marked permeability to calcium ions and is a major component of brain nicotinic receptors that are blocked by, and highly sensitive to, alpha-bungarotoxin. Once this receptor binds acetylcholine, it undergoes an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. This gene is located in a region identified as a major susceptibility locus for juvenile myoclonic epilepsy and a chromosomal location involved in the genetic transmission of schizophrenia. An evolutionarily recent partial duplication event in this region results in a hybrid containing sequence from this gene and a novel FAM7A gene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]
CHRNA7 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • epilepsy
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000636603.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.822 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000636603.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNA7
ENST00000636603.1
TSL:5
c.-131-1616T>C
intron
N/AENSP00000490513.1A0A1B0GVH2
CHRNA7
ENST00000637183.1
TSL:5
c.-43+51088T>C
intron
N/AENSP00000490365.1A0A1B0GV43
CHRNA7
ENST00000638106.1
TSL:5
c.-378-1616T>C
intron
N/AENSP00000490413.1A0A1B0GV86

Frequencies

GnomAD3 genomes
AF:
0.729
AC:
110833
AN:
152108
Hom.:
41869
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.556
Gnomad AMI
AF:
0.793
Gnomad AMR
AF:
0.725
Gnomad ASJ
AF:
0.779
Gnomad EAS
AF:
0.392
Gnomad SAS
AF:
0.794
Gnomad FIN
AF:
0.882
Gnomad MID
AF:
0.753
Gnomad NFE
AF:
0.827
Gnomad OTH
AF:
0.742
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.728
AC:
110890
AN:
152226
Hom.:
41887
Cov.:
33
AF XY:
0.731
AC XY:
54398
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.556
AC:
23084
AN:
41484
American (AMR)
AF:
0.725
AC:
11093
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.779
AC:
2705
AN:
3472
East Asian (EAS)
AF:
0.393
AC:
2034
AN:
5178
South Asian (SAS)
AF:
0.793
AC:
3829
AN:
4826
European-Finnish (FIN)
AF:
0.882
AC:
9372
AN:
10620
Middle Eastern (MID)
AF:
0.752
AC:
218
AN:
290
European-Non Finnish (NFE)
AF:
0.827
AC:
56273
AN:
68024
Other (OTH)
AF:
0.738
AC:
1559
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1423
2846
4270
5693
7116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
832
1664
2496
3328
4160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.789
Hom.:
72556
Bravo
AF:
0.703
Asia WGS
AF:
0.612
AC:
2132
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
2.4
DANN
Benign
0.70
PhyloP100
-0.94

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs3826029;
hg19: chr15-32321485;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.